Tahir Amin, director of the New York-based Initiative for Medicines, Access and Knowledge (I-MAK), a US-based NGO consisting of lawyers and scientists working towards increasing access to affordable medicines worldwide, told Intellectual Property Watch that India’s top court’s decision “affirms India’s position and policy on defining how it defines inventions from a patenting point of view for its development needs. It challenges the patenting standards and practices of the developed countries which are the ones really in much need of reform.”
Partner with us now to build a more just and equitable medicine system for all. Notice: JavaScript is required for this content.